Skip to main content
Clinical Trials/NCT02852421
NCT02852421
Completed
Not Applicable

Randomized Prospective Study to Evaluate Efficacy and Safety of Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks for Breast Surgery

Lawson Health Research Institute2 sites in 1 country70 target enrollmentAugust 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Neoplasms
Sponsor
Lawson Health Research Institute
Enrollment
70
Locations
2
Primary Endpoint
Sensory dermatomal spread
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Paravertebral block (PVB) has been shown to provide excellent analgesia for major breast surgeries resulting in reduced narcotic consumption, reduced nausea, improved quality of recovery, reduced chronic pain and possibly reduced metastasis with breast cancer. Traditionally, PVB is done by multiple injections below T1-T5 transverse processes. With multiple injections, the risk is increased for a pleural, an intraneural, and/or an intravascular injection. Recently, ultrasonography is being used to facilitate PVB. The use of ultrasound imaging enables real-time needle visualization during the procedure. This may improve efficacy and reduce the chances of complication like pneumothorax. Currently, there are no data comparing ultrasound-guided single injection technique with multiple injections technique with regards to extent of spread for PVB. Our objective is to investigate the extent of dermatomal spread of PVB when equal volumes of local anesthetic are injected at one versus five paravertebral sites for patients undergoing major breast surgery. In addition, the investigators wish to compare the performance time and duration of analgesia.

Methodology: After local REB approval, 72 patients undergoing a unilateral mastectomy with or without axillary node dissection will be randomized to receive either single or multiple injections PVB. The PVB will be performed in prone position under real-time ultrasound guidance using a para-sagittal approach.The patients in single injection group will receive single injection PVB at T3-T4 level with 25 ml of 0.5% ropivacaine and four subcutaneous sham injections. Patients in the multiple injection group will receive five injections of PVB from T1 to T5 level. 5 ml of 0.5% ropivacaine will be injected at each level. Pleural drift will be used as a sign of correct needle tip location and local anaesthetic spread. The pinprick method will be used to assess the extent of dermatomal blockade, 20 minutes following the completion of procedure. All patients will receive a standardized general anesthesia for the surgery. Any adverse events including pneumothorax, epidural spread, LA toxicity/seizure, total spinal, will be recorded.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
May 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sugantha Ganapathy

Professor

Lawson Health Research Institute

Eligibility Criteria

Inclusion Criteria

  • Females, age 18 to 80 years, scheduled to receive unilateral mastectomy surgery, with or without axillary node dissection
  • Able to give informed consent
  • Able to cooperate with study process
  • Availability of home telephone.

Exclusion Criteria

  • Patient refusal or lack of informed consent
  • allergy to local anesthetic and other medications used in the study
  • Bilateral mastectomies
  • Coexisting hematological disorder or with deranged coagulation parameters
  • Pre-existing major organ dysfunction such as hepatic and renal failure
  • Significant thoracic kyphoscoliosis
  • History of previous thoracic surgery.

Outcomes

Primary Outcomes

Sensory dermatomal spread

Time Frame: 20 minutes

20 minutes after block performance

Secondary Outcomes

  • Incidence of complication(24 hours)
  • VAS pain scores in PACU(6 hours)
  • Duration of self-reported numbness at the surgical site(24 hours)
  • Time to performance of procedure(Duration of procedure)
  • Cephalic and caudal dermatomal spread(20 minutes after block performance)

Study Sites (2)

Loading locations...

Similar Trials